Production (Stage)
Organogenesis Holdings Inc.
ORGO
$3.03
$0.155.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.84M | 7.67M | 12.33M | -17.04M | -2.10M |
| Total Depreciation and Amortization | 4.29M | 4.45M | 4.40M | 4.20M | 3.97M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.34M | 5.59M | 5.81M | 25.14M | 8.67M |
| Change in Net Operating Assets | -20.71M | -6.78M | -13.85M | -7.56M | -20.70M |
| Cash from Operations | -19.94M | 10.94M | 8.70M | 4.74M | -10.16M |
| Capital Expenditure | -3.63M | -3.36M | -2.57M | -1.88M | -2.22M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.63M | -3.36M | -2.57M | -1.88M | -2.22M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -285.00K | -62.62M | -1.68M | -1.67M | -1.67M |
| Issuance of Common Stock | 25.00K | 1.06M | 5.00K | 0.00 | 180.00K |
| Repurchase of Common Stock | -1.80M | -25.48M | -- | -54.00K | -1.12M |
| Issuance of Preferred Stock | -- | 120.69M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.06M | 33.65M | -1.68M | -1.73M | -2.61M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.62M | 41.23M | 4.45M | 1.13M | -14.99M |